|
Whether developing treatments for antibiotic-resistant infections or producing new drugs to help defend against bio-terrorism, Hematech, Inc. is utilizing the latest advances in technology to help fight diseases.
The company, headquartered in Sioux Falls, South Dakota, is currently developing cattle that can efficiently produce human antibodies. The genetically altered cattle, known as TC Bovine™, will be used for the production of large quantities of polyclonal antibodies. These antibodies are expected to help in the treatments of viral or bacterial infections, autoimmune disorders and other medical conditions occurring in humans.
 |
Awarded 2008 South Dakota Business of the Year by the
South Dakota Chamber of Commerce and Industry. Read more |
|
|
 |
A Subsidiary of
Kyowa Hakko Kirin Company, Ltd.
4401 South Technology Drive
Sioux Falls, SD 57106 |
|
|
